Comparison of treatment patterns and economic outcomes in metastatic breast cancer patients initiated on trastuzumab versus lapatinib: a retrospective analysis

Few studies have compared treatment patterns, healthcare resource utilization (HRU), and costs in patients with metastatic breast cancer (mBC) receiving HER2 directed therapy. This study evaluated these outcomes in patients receiving trastuzumab or lapatinib. Adult women with mBC, who were initiated...

Descripción completa

Detalles Bibliográficos
Autores principales: Guérin, Annie, Lalla, Deepa, Gauthier, Geneviève, Styles, Amy, Wu, Eric Q, Masaquel, Anthony, Brammer, Melissa G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048369/
https://www.ncbi.nlm.nih.gov/pubmed/24936383
http://dx.doi.org/10.1186/2193-1801-3-236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048369/
https://www.ncbi.nlm.nih.gov/pubmed/24936383
http://dx.doi.org/10.1186/2193-1801-3-236

Ejemplares similares